Zobrazeno 1 - 4
of 4
pro vyhledávání: '"FOR THE CLARITY STUDY GROUP"'
Autor:
Cook S, Vermersch P, Giovannoni G, Rammohan K, Rieckmann P, Sorensen PS, Hamlett A, Miret M, Weiner J, Viglietta V, Musch B, Greenberg SJ, CLARITY Study Group, COMI , GIANCARLO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::6c26d0e2809567ce507c43e52ccdfcf1
Autor:
GIOVANNONI G, COOK S, RAMMOHAN K. RIECKMANN P, SOELBERG SORENSEN P, VERMESCH P, CHANG P, HAMLETT A, MUSCH B, GREENBERG SJ, FOR THE CLARITY STUDY GROUP, COMI , GIANCARLO
BACKGROUND: Cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. We report the results of a 96-week phase 3 trial of a short-course oral tablet therapy in patients with relapsing-remitting multiple sclerosis. METHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::edba49c445cb38bb689be5da3f117a3c
Autor:
Sivaprasad, Sobha1 Sobha.sivaprasad@moorfields.nhs.uk, Prevost, A. Toby2, Vasconcelos, Joana C.2, Riddell, Amy3, Murphy, Caroline3, Kelly, Joanna3, Bainbridge, James4, Tudor-Edwards, Rhiannon5, Hopkins, David6, Hykin, Philip1, CLARITY Study Group
Publikováno v:
Lancet. 6/3/2017, Vol. 689 Issue 10085, p2193-2203. 11p.
